Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol

Nina Toft; Henrik Birgens; Jonas Abrahamsson; Per Bernell; Laimonas Griškevičius; Helene Hallböök; Mats Heyman; Mette Skov Holm; Erik Hulegårdh; Tobias Wirenfeldt Klausen; Hanne V Marquart; Olafur Gísli Jónsson; Ove Juul Nielsen; Petter Quist-Paulsen; Mervi Taskinen; Goda Vaitkeviciene; Kim Vettenranta; Ann Åsberg; Kjeld Schmiegelow

doi:10.1111/ejh.12097

Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol

Nina Toft, Henrik Birgens, Jonas Abrahamsson, Per Bernell, Laimonas Griškevičius, Helene Hallböök, Mats Heyman, Mette Skov Holm, Erik Hulegårdh, Tobias Wirenfeldt Klausen, Hanne V Marquart, Olafur Gísli Jónsson, Ove Juul Nielsen, Petter Quist-Paulsen, Mervi Taskinen, Goda Vaitkeviciene, Kim Vettenranta, Ann Åsberg, Kjeld Schmiegelow

126 Citations (Scopus)

Abstract

The prognosis of acute lymphoblastic leukemia is poorer in adults than in children. Studies have indicated that young adults benefit from pediatric treatment, although no upper age limit has been defined.

Original language	English
Journal	European Journal of Haematology
Volume	90
Issue number	5
Pages (from-to)	404-12
Number of pages	9
ISSN	0902-4441
DOIs	https://doi.org/10.1111/ejh.12097
Publication status	Published - May 2013

Keywords

Adolescent
Adult
Antineoplastic Combined Chemotherapy Protocols
Child
Child, Preschool
Cytogenetic Analysis
Dexamethasone
Doxorubicin
Drug Administration Schedule
Female
Hematopoietic Stem Cell Transplantation
Humans
Induction Chemotherapy
Infant
Male
Medication Adherence
Methotrexate
Middle Aged
Neoplasm, Residual
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Prednisone
Registries
Treatment Outcome
Vincristine
Young Adult

Access to Document

10.1111/ejh.12097

Cite this

Toft, N., Birgens, H., Abrahamsson, J., Bernell, P., Griškevičius, L., Hallböök, H., Heyman, M., Holm, M. S., Hulegårdh, E., Klausen, T. W., Marquart, H. V., Jónsson, O. G., Nielsen, O. J., Quist-Paulsen, P., Taskinen, M., Vaitkeviciene, G., Vettenranta, K., Åsberg, A., & Schmiegelow, K. (2013). Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol. European Journal of Haematology, 90(5), 404-12. https://doi.org/10.1111/ejh.12097

Toft, N, Birgens, H, Abrahamsson, J, Bernell, P, Griškevičius, L, Hallböök, H, Heyman, M, Holm, MS, Hulegårdh, E, Klausen, TW, Marquart, HV, Jónsson, OG, Nielsen, OJ, Quist-Paulsen, P, Taskinen, M, Vaitkeviciene, G, Vettenranta, K, Åsberg, A & Schmiegelow, K 2013, 'Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol', European Journal of Haematology, vol. 90, no. 5, pp. 404-12. https://doi.org/10.1111/ejh.12097

@article{a5c0fc9acde849fe8a8d69465761f7a6,

title = "Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol",

abstract = "The prognosis of acute lymphoblastic leukemia is poorer in adults than in children. Studies have indicated that young adults benefit from pediatric treatment, although no upper age limit has been defined.",

keywords = "Adolescent, Adult, Antineoplastic Combined Chemotherapy Protocols, Child, Child, Preschool, Cytogenetic Analysis, Dexamethasone, Doxorubicin, Drug Administration Schedule, Female, Hematopoietic Stem Cell Transplantation, Humans, Induction Chemotherapy, Infant, Male, Medication Adherence, Methotrexate, Middle Aged, Neoplasm, Residual, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prednisone, Registries, Treatment Outcome, Vincristine, Young Adult",

author = "Nina Toft and Henrik Birgens and Jonas Abrahamsson and Per Bernell and Laimonas Gri{\v s}kevi{\v c}ius and Helene Hallb{\"o}{\"o}k and Mats Heyman and Holm, \{Mette Skov\} and Erik Huleg{\aa}rdh and Klausen, \{Tobias Wirenfeldt\} and Marquart, \{Hanne V\} and J{\'o}nsson, \{Olafur G{\'i}sli\} and Nielsen, \{Ove Juul\} and Petter Quist-Paulsen and Mervi Taskinen and Goda Vaitkeviciene and Kim Vettenranta and Ann {\AA}sberg and Kjeld Schmiegelow",

note = "{\textcopyright} 2013 John Wiley \& Sons A/S.",

year = "2013",

month = may,

doi = "10.1111/ejh.12097",

language = "English",

volume = "90",

pages = "404--12",

journal = "European Journal of Haematology",

issn = "0902-4441",

publisher = "John Wiley and Sons Inc.",

number = "5",

}

TY - JOUR

T1 - Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol

AU - Toft, Nina

AU - Birgens, Henrik

AU - Abrahamsson, Jonas

AU - Bernell, Per

AU - Griškevičius, Laimonas

AU - Hallböök, Helene

AU - Heyman, Mats

AU - Holm, Mette Skov

AU - Hulegårdh, Erik

AU - Klausen, Tobias Wirenfeldt

AU - Marquart, Hanne V

AU - Jónsson, Olafur Gísli

AU - Nielsen, Ove Juul

AU - Quist-Paulsen, Petter

AU - Taskinen, Mervi

AU - Vaitkeviciene, Goda

AU - Vettenranta, Kim

AU - Åsberg, Ann

AU - Schmiegelow, Kjeld

PY - 2013/5

Y1 - 2013/5

N2 - The prognosis of acute lymphoblastic leukemia is poorer in adults than in children. Studies have indicated that young adults benefit from pediatric treatment, although no upper age limit has been defined.

AB - The prognosis of acute lymphoblastic leukemia is poorer in adults than in children. Studies have indicated that young adults benefit from pediatric treatment, although no upper age limit has been defined.

KW - Adolescent

KW - Adult

KW - Antineoplastic Combined Chemotherapy Protocols

KW - Child

KW - Child, Preschool

KW - Cytogenetic Analysis

KW - Dexamethasone

KW - Doxorubicin

KW - Drug Administration Schedule

KW - Female

KW - Hematopoietic Stem Cell Transplantation

KW - Humans

KW - Induction Chemotherapy

KW - Infant

KW - Male

KW - Medication Adherence

KW - Methotrexate

KW - Middle Aged

KW - Neoplasm, Residual

KW - Precursor Cell Lymphoblastic Leukemia-Lymphoma

KW - Prednisone

KW - Registries

KW - Treatment Outcome

KW - Vincristine

KW - Young Adult

UR - https://www.scopus.com/pages/publications/84876720671

U2 - 10.1111/ejh.12097

DO - 10.1111/ejh.12097

M3 - Journal article

C2 - 23461707

SN - 0902-4441

VL - 90

SP - 404

EP - 412

JO - European Journal of Haematology

JF - European Journal of Haematology

IS - 5

ER -

Risk group assignment differs for children and adults 1-45 yr with acute lymphoblastic leukemia treated by the NOPHO ALL-2008 protocol

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this